AppsFlyer, the mobile attribution and marketing analytics platform, has appointed Antony Wilcox as Director of Agency Alliances, Asia Pacific – its first strategic hire dedicated to agencies in Asia-Pacific (APAC).
Given the nature of APAC’s position as a mobile-first region, mobile knowledge and adoption is a crucial ingredient for agencies. With mobile investment and digital ad spend on the rise in the region, marketers will increasingly rely on robust cross-media measurement and data analysis capabilities to optimise their investments, as well as ensure brand safety and viewability. Mr Wilcox will be tasked with leading AppsFlyer’s efforts in helping agencies realise the potential of a data-driven approach to marketing across APAC.
Prior to joining AppsFlyer, Mr Wilcox served as Regional Director Asia at Datalicious, a leader in web attribution and analytics, and led the setup and expansion of the company in South East Asia, India and South Korea.
“Antony’s experience will be invaluable in helping agencies increase their adoption to mobile and work with measurement more efficiently on behalf of brands. His extensive background in the space makes him uniquely positioned to usher APAC based agencies through this journey. We’re excited to be deepening our presence in the region, and continue in supporting all of the different players in the mobile advertising ecosystem, from advertisers, to publishers, and agencies.” said Ronen Mense, VP, Asia at AppsFlyer.
“AppsFlyer has a significant presence throughout Asia-Pacific and we foresee tremendous opportunities in working more closely with media agencies and ensuring they’re best-positioned to deliver success to their brand clients. We’re lucky to have strategic relationships with some of the region’s largest agencies, and this new role will allow us to continue to foster and build on these highly valued relationships amidst a rapidly developing Asian mobile market. It is an exciting time for the mobile ecosystem, and I cannot wait to see how far we’ll go,” said Mr Wilcox.